141 related articles for article (PubMed ID: 11402475)
1. Alternative therapy use and adherence to antihyperlipidemic drugs in a lipid clinic.
O'Donnell DC; Brown CM; Piziak VK
Am J Health Syst Pharm; 2001 Jun; 58(11):1017-21. PubMed ID: 11402475
[No Abstract] [Full Text] [Related]
2. Factors associated with low compliance with lipid-lowering drugs in hyperlipidemic patients.
Kiortsis DN; Giral P; Bruckert E; Turpin G
J Clin Pharm Ther; 2000 Dec; 25(6):445-51. PubMed ID: 11123498
[TBL] [Abstract][Full Text] [Related]
3. Clinical and economic impact of clinical pharmacy service on hyperlipidemic management in Hong Kong.
Chung JS; Lee KK; Tomlinson B; Lee VW
J Cardiovasc Pharmacol Ther; 2011 Mar; 16(1):43-52. PubMed ID: 20924095
[TBL] [Abstract][Full Text] [Related]
4. Adherence to antihyperlipidemic medication and lipid control in diabetic Veterans Affairs patients with psychotic disorders.
Nelson LA; Graham MR; Lindsey CC; Rasu RS
Psychosomatics; 2011; 52(4):310-8. PubMed ID: 21777713
[TBL] [Abstract][Full Text] [Related]
5. Non-attendance at secondary prevention clinics: the effect on lipid management.
McLeod AL; Brooks L; Taylor V; Wylie A; Currie PF; Dewhurst NG
Scott Med J; 2005 May; 50(2):54-6. PubMed ID: 15977514
[TBL] [Abstract][Full Text] [Related]
6. Getting the skinny on lipid-lowering drugs.
Kuncl N; Nelson KM
Nursing; 2000 Jul; 30(7):52-3. PubMed ID: 10983101
[No Abstract] [Full Text] [Related]
7. The cost and effectiveness of adherence-improving interventions for antihypertensive and lipid-lowering drugs*.
Chapman RH; Ferrufino CP; Kowal SL; Classi P; Roberts CS
Int J Clin Pract; 2010 Jan; 64(2):169-81. PubMed ID: 20089007
[TBL] [Abstract][Full Text] [Related]
8. Prevalence, factors influencing and knowledge about adherence to lipid-lowering therapy among hyperlipidemia patients.
Devaraj NK; Mohamed M; Hussein N
Med J Malaysia; 2017 Jun; 72(3):157-164. PubMed ID: 28733563
[TBL] [Abstract][Full Text] [Related]
9. Adherence to lipid-lowering drug therapy among members of the Canadian Forces.
Ma J; Vaillancourt R; Bennett C
Mil Med; 2008 Jul; 173(7):666-70. PubMed ID: 18700601
[TBL] [Abstract][Full Text] [Related]
10. Patient is the ultimate measure of any plan of therapy.
Hughes JH
Mil Med; 2008 Jul; 173(7):iii. PubMed ID: 18700588
[No Abstract] [Full Text] [Related]
11. Adherence.
Foody JM; Benner JS; Frishman W
J Clin Hypertens (Greenwich); 2007 Apr; 9(4):271-5. PubMed ID: 17396070
[TBL] [Abstract][Full Text] [Related]
12. [Clinical observations on antihyperlipidemic action of laminarin sulfate in 40 cases.(author's transl)].
Yu BQ
Zhonghua Xin Xue Guan Bing Za Zhi; 1981 Sep; 9(3):212-3. PubMed ID: 7338177
[No Abstract] [Full Text] [Related]
13. Clinical observation on hyperlipemia treated with antihyperlipidemic decoction.
Xu CF; Lin XR; Wang YK
J Tradit Chin Med; 2009 Jun; 29(2):121-4. PubMed ID: 19663099
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of chart prompts to improve physician compliance with the National Cholesterol Education Program guidelines.
Stamos TD; Shaltoni H; Girard SA; Parrillo JE; Calvin JE
Am J Cardiol; 2001 Dec; 88(12):1420-3, A8. PubMed ID: 11741565
[No Abstract] [Full Text] [Related]
15. Evaluation of lipid-lowering therapies at an ethnically diverse clinic.
Huxtable LM; Borowski D
Am J Health Syst Pharm; 2003 Jun; 60(12):1282-3. PubMed ID: 12845930
[No Abstract] [Full Text] [Related]
16. Communicating the benefits of chronic preventive therapy: does the format of efficacy data determine patients' acceptance of treatment?
Hux JE; Naylor CD
Med Decis Making; 1995; 15(2):152-7. PubMed ID: 7783576
[TBL] [Abstract][Full Text] [Related]
17. Adherence to lipid-lowering agents.
Ege MR; Yucel O; Acikgoz S
Int J Clin Pract; 2011 Dec; 65(12):1321. PubMed ID: 22093541
[No Abstract] [Full Text] [Related]
18. Evaluation of a pharmacist-managed lipid clinic that uses point-of-care lipid testing.
Gerrald KR; Dixon DL; Barnette DJ; Williams VG
J Clin Lipidol; 2010; 4(2):120-5. PubMed ID: 21122639
[TBL] [Abstract][Full Text] [Related]
19. Primary prevention of ischaemic heart disease with lipid-lowering drugs.
Lancet; 1988 Feb; 1(8581):333-4. PubMed ID: 2893141
[No Abstract] [Full Text] [Related]
20. How can adherence to lipid-lowering medication be improved? A systematic review of randomized controlled trials.
Schedlbauer A; Schroeder K; Fahey T
Fam Pract; 2007 Sep; 24(4):380-7. PubMed ID: 17630270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
